Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dugel Pravin | Director | 7 | $0 | $0 | 2021-06-30 |
| Dalal Anupam | Director | 6 | $0 | $0 | 2021-06-30 |
| Cohen Cheryl | Director | 7 | $0 | $0 | 2021-06-30 |
| Castelein Caley | Director | 8 | $0 | $0 | 2021-06-30 |
| Prelack Steven | Director | 5 | $0 | $0 | 2021-06-30 |
| OrbiMed Capital GP V LLC | 10% Owner | 3 | $0 | $41.9K | 2020-12-08 |
| Marek Regina | Vice President of Finance | 2 | $0 | $0 | 2020-03-16 |
| Gardner Joseph H. | President | 7 | $8.6K | $0 | 2020-03-16 |
| PETERS KEVIN G. | See Remarks | 5 | $0 | $0 | 2020-03-16 |
| Khuong Chau Quang | Director, 10% Owner | 3 | $2.99M | $0 | 2019-06-18 |
| Satter Muneer A | Director, 10% Owner | 34 | $8.19M | $0 | 2019-06-18 |
| ROGERS MICHAEL W | See Remarks | 5 | $0 | $0 | 2019-05-14 |
| HOFFMAN STEPHEN J | Chief Executive Officer | 6 | $64.1K | $0 | 2019-05-14 |
| NOVARTIS AG | 10% Owner | 9 | $0 | $1.11M | 2019-04-26 |
| Novartis Bioventures Ltd | 10% Owner | 12 | $0 | $684.9K | 2019-04-15 |
| PAKOLA STEVE | Chief Medical Officer | 2 | $0 | $0 | 2019-02-15 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 1 | $2.99M | $0 | 2018-06-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cohen Cheryl | Director | A Award | 2021-06-30 | 2021-07-02 | 8,140 | $1.52 | $12.4K | 16,160 | SEC↗ |
| Castelein Caley | Director | A Award | 2021-06-30 | 2021-07-02 | 7,811 | $1.52 | $11.9K | 295,414 | SEC↗ |
| Dugel Pravin | Director | A Award | 2021-06-30 | 2021-07-02 | 6,331 | $1.52 | $9.6K | 12,568 | SEC↗ |
| Prelack Steven | Director | A Award | 2021-06-30 | 2021-07-02 | 12,334 | $1.52 | $18.7K | 24,485 | SEC↗ |
| Dalal Anupam | Director | A Award | 2021-06-30 | 2021-07-02 | 7,400 | $1.52 | $11.2K | 16,959 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2021-06-17 | 2021-06-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Prelack Steven | Director | A Award | 2021-03-31 | 2021-04-02 | 12,151 | $1.54 | $18.7K | 12,151 | SEC↗ |
| Castelein Caley | Director | A Award | 2021-03-31 | 2021-04-02 | 7,696 | $1.54 | $11.9K | 287,603 | SEC↗ |
| Dalal Anupam | Director | A Award | 2021-03-31 | 2021-04-02 | 7,290 | $1.54 | $11.2K | 9,559 | SEC↗ |
| Dugel Pravin | Director | A Award | 2021-03-31 | 2021-04-02 | 6,237 | $1.54 | $9.6K | 6,237 | SEC↗ |
| Cohen Cheryl | Director | A Award | 2021-03-31 | 2021-04-02 | 8,020 | $1.54 | $12.4K | 8,020 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2021-02-01 | 2021-02-03 | 17,857 | — | $0 | 17,857 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2021-02-01 | 2021-02-03 | 17,857 | — | $0 | 17,857 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2021-02-01 | 2021-02-03 | 17,857 | — | $0 | 17,857 | SEC↗ |
| Dugel Pravin | Director | A Award deriv | 2021-02-01 | 2021-02-03 | 17,857 | — | $0 | 17,857 | SEC↗ |
| OrbiMed Capital GP V LLC | 10% Owner | X Exercise deriv | 2020-12-08 | 2020-12-10 | 21,400 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP V LLC | 10% Owner | S Sale | 2020-12-08 | 2020-12-10 | 21,400 | $1.96 | $41.9K | 0 | SEC↗ |
| OrbiMed Capital GP V LLC | 10% Owner | X Exercise | 2020-12-08 | 2020-12-10 | 21,400 | $0.96 | $20.5K | 21,400 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| Prelack Steven | Director | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| Dugel Pravin | Director | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| Marek Regina | Vice President of Finance | A Award deriv | 2020-03-16 | 2020-03-18 | 93,000 | — | $0 | 93,000 | SEC↗ |
| PETERS KEVIN G. | See Remarks | A Award deriv | 2020-03-16 | 2020-03-18 | 129,000 | — | $0 | 129,000 | SEC↗ |
| Gardner Joseph H. | President | A Award deriv | 2020-03-16 | 2020-03-18 | 155,000 | — | $0 | 155,000 | SEC↗ |
| Marek Regina | Vice President of Finance | A Award deriv | 2019-11-04 | 2019-11-06 | 44,300 | — | $0 | 44,300 | SEC↗ |
| Gardner Joseph H. | President | P Buy | 2019-07-10 | 2019-07-10 | 5,000 | $0.81 | $4.1K | 453,019 | SEC↗ |
| Gardner Joseph H. | President | P Buy | 2019-07-03 | 2019-07-08 | 5,000 | $0.90 | $4.5K | 448,019 | SEC↗ |
| Prelack Steven | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Dugel Pravin | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| PETERS KEVIN G. | See Remarks | A Award deriv | 2019-05-14 | 2019-05-16 | 63,250 | — | $0 | 63,250 | SEC↗ |
| PETERS KEVIN G. | See Remarks | A Award deriv | 2019-05-14 | 2019-05-16 | 266,550 | — | $0 | 266,550 | SEC↗ |
| ROGERS MICHAEL W | See Remarks | A Award deriv | 2019-05-14 | 2019-05-16 | 169,500 | — | $0 | 169,500 | SEC↗ |
| ROGERS MICHAEL W | See Remarks | A Award deriv | 2019-05-14 | 2019-05-16 | 430,500 | — | $0 | 430,500 | SEC↗ |
| Gardner Joseph H. | President | A Award deriv | 2019-05-14 | 2019-05-16 | 349,350 | — | $0 | 349,350 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | A Award deriv | 2019-05-14 | 2019-05-16 | 709,050 | — | $0 | 709,050 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-04-26 | 2019-04-29 | 138,704 | $1.03 | $142.9K | 4,049,804 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-04-25 | 2019-04-29 | 563,096 | $1.03 | $580.0K | 4,188,508 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-04-24 | 2019-04-24 | 16,403 | $1.03 | $16.9K | 4,751,604 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-04-23 | 2019-04-24 | 27,554 | $1.03 | $28.4K | 4,768,007 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-04-22 | 2019-04-24 | 7,100 | $0.97 | $6.9K | 4,795,561 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-15 | 2019-04-15 | 28,794 | $0.99 | $28.5K | 4,802,661 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-12 | 2019-04-15 | 30,908 | $1.04 | $32.1K | 4,831,455 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-11 | 2019-04-15 | 57,438 | $1.08 | $62.0K | 4,862,363 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-10 | 2019-04-10 | 140,230 | $1.09 | $152.9K | 4,919,801 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-09 | 2019-04-10 | 32,991 | $1.01 | $33.3K | 5,060,031 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-08 | 2019-04-10 | 27,525 | $1.02 | $28.1K | 5,093,022 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-05 | 2019-04-05 | 24,661 | $1.02 | $25.2K | 5,120,547 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-04 | 2019-04-05 | 47,900 | $1.01 | $48.4K | 5,145,208 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-03 | 2019-04-05 | 58,033 | $0.96 | $55.7K | 5,193,108 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-02 | 2019-04-02 | 51,754 | $0.97 | $50.2K | 5,251,141 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-04-01 | 2019-04-02 | 116,909 | $0.95 | $111.1K | 5,302,895 | SEC↗ |
| Novartis Bioventures Ltd | 10% Owner | S Sale | 2019-03-29 | 2019-04-02 | 63,100 | $0.91 | $57.4K | 5,419,804 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-03-28 | 2019-03-28 | 88,835 | $0.94 | $83.5K | 5,482,904 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-03-27 | 2019-03-28 | 50,749 | $0.99 | $50.2K | 5,571,739 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2019-03-26 | 2019-03-28 | 177,762 | $1.01 | $179.5K | 5,622,488 | SEC↗ |
| ROGERS MICHAEL W | Chief Financial Officer | A Award deriv | 2019-02-15 | 2019-02-20 | 215,328 | — | $0 | 215,328 | SEC↗ |
| PETERS KEVIN G. | Chief Scientific Officer | A Award deriv | 2019-02-15 | 2019-02-20 | 125,000 | — | $0 | 125,000 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | A Award deriv | 2019-02-15 | 2019-02-20 | 365,000 | — | $0 | 365,000 | SEC↗ |
| Gardner Joseph H. | President | A Award deriv | 2019-02-15 | 2019-02-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PAKOLA STEVE | Chief Medical Officer | A Award deriv | 2019-02-15 | 2019-02-20 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-10 | 2019-01-10 | 23,818 | $2.45 | $58.4K | 5,621,835 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-09 | 2019-01-10 | 20,000 | $2.39 | $47.8K | 5,598,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-08 | 2019-01-10 | 20,000 | $2.20 | $44.0K | 5,578,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-07 | 2019-01-07 | 20,000 | $2.18 | $43.6K | 5,558,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-04 | 2019-01-07 | 20,000 | $2.12 | $42.4K | 5,538,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-03 | 2019-01-07 | 20,000 | $2.08 | $41.6K | 5,518,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2019-01-02 | 2019-01-02 | 20,000 | $1.94 | $38.8K | 5,498,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-31 | 2019-01-02 | 20,000 | $1.75 | $35.0K | 5,478,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-28 | 2019-01-02 | 20,000 | $1.72 | $34.4K | 5,458,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-27 | 2018-12-27 | 20,000 | $1.67 | $33.4K | 5,438,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-26 | 2018-12-27 | 20,000 | $1.69 | $33.8K | 5,418,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-21 | 2018-12-27 | 20,000 | $1.84 | $36.8K | 5,398,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-20 | 2018-12-20 | 20,000 | $1.85 | $37.0K | 5,378,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-19 | 2018-12-20 | 20,000 | $1.92 | $38.4K | 5,358,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-18 | 2018-12-20 | 20,000 | $1.99 | $39.8K | 5,338,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-14 | 2018-12-14 | 20,000 | $2.00 | $40.0K | 5,318,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-13 | 2018-12-14 | 20,000 | $2.02 | $40.4K | 5,298,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-12 | 2018-12-14 | 20,000 | $2.05 | $41.0K | 5,278,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-11 | 2018-12-11 | 20,000 | $2.09 | $41.8K | 5,258,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-10 | 2018-12-11 | 20,000 | $2.13 | $42.6K | 5,238,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-07 | 2018-12-11 | 20,000 | $2.14 | $42.8K | 5,218,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-06 | 2018-12-06 | 20,000 | $2.18 | $43.6K | 5,198,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-04 | 2018-12-06 | 20,000 | $2.10 | $42.0K | 5,178,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-12-03 | 2018-12-06 | 20,000 | $1.99 | $39.8K | 5,158,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-11-30 | 2018-11-30 | 20,000 | $1.98 | $39.6K | 5,138,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-11-29 | 2018-11-30 | 20,000 | $2.01 | $40.2K | 5,118,017 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-11-28 | 2018-11-30 | 20,000 | $1.94 | $38.8K | 5,098,017 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | P Buy | 2018-11-12 | 2018-11-14 | 30,000 | $2.01 | $60.3K | 31,967 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | P Buy | 2018-11-09 | 2018-11-14 | 1,967 | $1.95 | $3.8K | 1,967 | SEC↗ |
| Dugel Pravin | Director | A Award deriv | 2018-10-26 | 2018-11-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Castelein Caley | Director | J Other | 2018-09-24 | 2018-09-26 | 268,987 | — | $0 | 279,907 | SEC↗ |
| Castelein Caley | Director | D To issuer | 2018-09-24 | 2018-09-26 | 1,603,526 | — | $0 | 0 | SEC↗ |
| NOVARTIS AG | 10% Owner | S Sale | 2018-08-20 | 2018-08-22 | 5,300 | $3.90 | $20.7K | 5,800,250 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 777,500 | $3.85 | $2.99M | 5,193,946 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 777,500 | $3.85 | $2.99M | 5,193,946 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-06-28 | 2018-06-29 | 1,818,182 | $3.85 | $7.00M | 5,078,017 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 42,800 | — | $0 | 42,800 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Prelack Steven | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Dugel Pravin | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| Gardner Joseph H. | President | A Award deriv | 2018-04-23 | 2018-04-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PAKOLA STEVE | Chief Medical Officer | A Award deriv | 2018-04-23 | 2018-04-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ROGERS MICHAEL W | Chief Financial Officer | A Award deriv | 2018-04-23 | 2018-04-25 | 144,000 | — | $0 | 144,000 | SEC↗ |
| PETERS KEVIN G. | Chief Scientific Officer | A Award deriv | 2018-04-23 | 2018-04-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | A Award deriv | 2018-04-23 | 2018-04-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-03-23 | 2018-03-23 | 1,000 | $5.00 | $5.0K | 3,259,835 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-03-21 | 2018-03-23 | 4,000 | $4.85 | $19.4K | 3,258,835 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-03-20 | 2018-03-21 | 5,400 | $4.97 | $26.8K | 3,254,835 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2018-03-19 | 2018-03-21 | 7,600 | $4.96 | $37.7K | 3,249,435 | SEC↗ |
| ROGERS MICHAEL W | Chief Financial Officer | A Award deriv | 2017-12-14 | 2017-12-18 | 293,006 | $5.50 | $1.61M | 0 | SEC↗ |
| Gardner Joseph H. | President | A Award deriv | 2017-12-14 | 2017-12-18 | 135,000 | $5.50 | $742.5K | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Chief Executive Officer | A Award deriv | 2017-12-14 | 2017-12-18 | 586,012 | $5.50 | $3.22M | 0 | SEC↗ |